Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity (Q46988032)
Jump to navigation
Jump to search
scientific article published on 21 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity |
scientific article published on 21 September 2007 |
Statements
1 reference
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity (English)
1 reference
Joachim Rudolph
1 reference
William P Esler
1 reference
Stephen O'connor
1 reference
Philip D G Coish
1 reference
Philip L Wickens
1 reference
Michael Brands
1 reference
Donald E Bierer
1 reference
Brian T Bloomquist
1 reference
Georgiy Bondar
1 reference
Libing Chen
1 reference
Chih-Yuan Chuang
1 reference
Thomas H Claus
1 reference
Zahra Fathi
1 reference
Wenlang Fu
1 reference
Uday R Khire
1 reference
James A Kristie
1 reference
Xiao-Gao Liu
1 reference
Derek B Lowe
1 reference
Andrea C McClure
1 reference
Martin Michels
1 reference
Astrid A Ortiz
1 reference
Philip D Ramsden
1 reference
Robert W Schoenleber
1 reference
Tatiana E Shelekhin
1 reference
Alexandros Vakalopoulos
1 reference
Weifeng Tang
1 reference
Lei Wang
1 reference
Lin Yi
1 reference
Stephen J Gardell
1 reference
James N Livingston
1 reference
Laurel J Sweet
1 reference
William H Bullock
1 reference
21 September 2007
1 reference
1 reference
50
1 reference
5202-5216
1 reference
21
1 reference
Identifiers
1 reference
1 reference